1. Home
  2. MLTX vs SGHC Comparison

MLTX vs SGHC Comparison

Compare MLTX & SGHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MLTX
  • SGHC
  • Stock Information
  • Founded
  • MLTX 2021
  • SGHC 2020
  • Country
  • MLTX Switzerland
  • SGHC Guernsey
  • Employees
  • MLTX N/A
  • SGHC N/A
  • Industry
  • MLTX Biotechnology: Pharmaceutical Preparations
  • SGHC Services-Misc. Amusement & Recreation
  • Sector
  • MLTX Health Care
  • SGHC Consumer Discretionary
  • Exchange
  • MLTX Nasdaq
  • SGHC Nasdaq
  • Market Cap
  • MLTX 2.8B
  • SGHC 5.8B
  • IPO Year
  • MLTX N/A
  • SGHC N/A
  • Fundamental
  • Price
  • MLTX $50.30
  • SGHC $11.64
  • Analyst Decision
  • MLTX Strong Buy
  • SGHC Strong Buy
  • Analyst Count
  • MLTX 7
  • SGHC 7
  • Target Price
  • MLTX $73.33
  • SGHC $12.57
  • AVG Volume (30 Days)
  • MLTX 429.2K
  • SGHC 1.7M
  • Earning Date
  • MLTX 08-06-2025
  • SGHC 08-06-2025
  • Dividend Yield
  • MLTX N/A
  • SGHC 1.34%
  • EPS Growth
  • MLTX N/A
  • SGHC 278.66
  • EPS
  • MLTX N/A
  • SGHC 0.27
  • Revenue
  • MLTX N/A
  • SGHC $1,939,039,555.00
  • Revenue This Year
  • MLTX $103.42
  • SGHC $19.99
  • Revenue Next Year
  • MLTX N/A
  • SGHC $9.01
  • P/E Ratio
  • MLTX N/A
  • SGHC $42.53
  • Revenue Growth
  • MLTX N/A
  • SGHC 21.70
  • 52 Week Low
  • MLTX $31.42
  • SGHC $2.94
  • 52 Week High
  • MLTX $58.26
  • SGHC $12.18
  • Technical
  • Relative Strength Index (RSI)
  • MLTX 63.01
  • SGHC 76.04
  • Support Level
  • MLTX $46.37
  • SGHC $10.61
  • Resistance Level
  • MLTX $49.80
  • SGHC $12.18
  • Average True Range (ATR)
  • MLTX 1.75
  • SGHC 0.42
  • MACD
  • MLTX 0.04
  • SGHC 0.08
  • Stochastic Oscillator
  • MLTX 84.41
  • SGHC 81.39

About MLTX MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients.

About SGHC Super Group (SGHC) Limited

Super Group (SGHC) Ltd is a holding company that operates online sports betting and gaming businesses. The company's reportable segments are Betway, Spin, and Other. A majority of its revenue is generated from the Betway segment, which is a single-brand online sports betting and casino offering with licenses to operate throughout Europe, the Americas, and Africa. Spin is the company's multi-brand online casino offering, having a diverse portfolio of casino brands such as Jackpot City, Spin Casino, Dream Bingo, Mirror Bingo, etc., designed to be culturally relevant globally while aiming to offer a wide range of casino products. Geographically, the company generates maximum revenue from Africa and Middle East, followed by North America, Europe, Asia-Pacific, and South/Latin America.

Share on Social Networks: